文献速递妇科

卵巢前哨淋巴结定位可行性研究:纪念斯隆凯特琳癌症中心卵巢团队研究

A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes: A Memorial Sloan Kettering Cancer Center Team Ovary Study.
PubMed 文献 · Obstet Gynecol · 2025-10-02

前瞻性纳入40例附件肿块患者,每组10例评估四种吲哚菁绿注射方法定位卵巢前哨淋巴结。方法3和方法4(骨盆漏斗韧带注射)定位率分别为50.0%和70.0%,术者认为可行;方法1和方法2因操作繁琐和腹膜染色过多难以识别。结论认为骨盆漏斗韧带注射应在可能附件恶性肿瘤患者中评估。

要点

  • 附件肿块切除前后行骨盆漏斗韧带吲哚菁绿注射,前哨淋巴结定位率相似(50.0% vs 70.0%)。
  • 方法1和方法2因操作繁琐及腹膜染色过多导致前哨淋巴结识别困难。
  • 仅1例前哨淋巴结位于附件肿块对侧,除3例外均位于腹主动脉旁区域。

核心结论

  • 附件肿块切除前或后行骨盆漏斗韧带吲哚菁绿注射,前哨淋巴结定位率相似,术者认为可行。
  • 仅1例前哨淋巴结位于附件肿块对侧,除3例外均位于腹主动脉旁区域。
  • 作者认为骨盆漏斗韧带注射应在可能附件恶性肿瘤的患者中评估,包括前哨淋巴结切除。

研究设计与样本

  • 前瞻性纳入因附件肿块就诊的患者,排除腹膜癌病患者。
  • 共40例患者入组,四种注射方法每组10例。

主要发现

  • 方法1(输卵管腔内注射):20.0%的前哨淋巴结定位,均位于同侧腹主动脉旁淋巴结床。
  • 方法2(卵巢旁腹膜注射):10.0%定位,仅位于同侧腹主动脉旁淋巴结床。
  • 方法3(附件肿块切除后骨盆漏斗韧带注射):50.0%定位,同侧腹主动脉旁淋巴结床n=3、对侧腹主动脉旁淋巴结床n=1、同侧盆腔淋巴结床n=1。
  • 方法4(附件肿块切除前骨盆漏斗韧带注射):70.0%定位,同侧腹主动脉旁淋巴结床n=5、同侧盆腔淋巴结床n=2。
  • 术者报告方法1和方法2操作繁琐,过多腹膜染色使前哨淋巴结识别困难;未报告注射相关并发症。

临床怎么用

  • 作者认为骨盆漏斗韧带注射应在可能附件恶性肿瘤的患者中评估,包括前哨淋巴结切除。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To evaluate four methods of injecting indocyanine green (ICG) around the adnexa and identify the optimal technique for ovarian sentinel lymph node (SLN) mapping. METHOD: Patients presenting for management of an adnexal mass were prospectively enrolled. Patients with peritoneal carcinomatosis were excluded. Four injection methods were evaluated: 1) intratubal, 2) paraovarian peritoneum, 3) infundibulopelvic (IP) ligament after resection of the adnexal mass, and 4) IP ligament before resection of the adnexal mass. Two mL of ICG was injected, and at least 10 minutes of transit time was allowed. The ipsilateral and contralateral pelvic and para-aortic lymph node beds were evaluated for ICG uptake. Retroperitoneal nodal resection was performed if indicated. EXPERIENCE: Forty patients were enrolled, 10 in each group. For method 1, 20.0% of SLNs mapped, all to the ipsilateral para-aortic lymph node bed. For method 2, 10.0% mapped, only to the ipsilateral para-aortic lymph node bed. For method 3, 50.0% mapped to the ipsilateral para-aortic lymph node bed (n=3), contralateral para-aortic lymph node bed (n=1), or ipsilateral pelvic lymph node bed (n=1). For method 4, 70.0% mapped to the ipsilateral para-aortic lymph node bed (n=5) or ipsilateral pelvic lymph node bed (n=2). Surgeons reported methods 1 and 2 as cumbersome, and excessive peritoneal staining made SLN identification difficult. No injection-related complications were reported. CONCLUSION: Injection of ICG into the IP ligament before or after adnexal mass resection led to similar rates of SLN mapping and was deemed feasible by surgeons. Only one SLN was identified contralateral to the adnexal mass, and all but three mapped to the para-aortic region. Injection into the IP ligament should be evaluated in patients with likely adnexal malignancy, including SLN resection.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Filippova OT, Chi DS, Iasonos A, et al. A Feasibility Study for Mapping Ovarian Sentinel Lymph Nodes: A Memorial Sloan Kettering Cancer Center Team Ovary Study. Obstet Gynecol. 2025. PMID: 41037815. doi:10.1097/AOG.0000000000006077

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。